Picture of Reviva Pharmaceuticals Holdings logo

RVPH — Reviva Pharmaceuticals Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Reviva Pharmaceuticals Holdings Inc Reports Third Quarter 2022 Financial Results

Nov 14 (Reuters) - Reviva Pharmaceuticals Holdings, Inc.
 RVPH.O :
    * REVIVA PHARMACEUTICALS HOLDINGS, INC. REPORTS THIRD
QUARTER 2022
FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
    * REVIVA PHARMACEUTICALS - AS OF SEPTEMBER 30, 2022, CO'S
CASH
TOTALED ABOUT $23.2 MILLION COMPARED TO ABOUT $29.7 MILLION AS
OF DECEMBER 31, 2021
    * REVIVA - BELIEVES CO'S CASH AS OF SEPT 30, 2022 WILL BE
SUFFICIENT TO FUND CURRENT OPERATING PLANS THROUGH AT LEAST NOV
2023
    * REVIVA PHARMACEUTICALS HOLDINGS, INC. - QTRLY LOSS PER
SHARE
$0.18

Source text for Eikon:  ID:nGNX4ky56T 
Further company coverage:  RVPH.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Reviva Pharmaceuticals Holdings

See all news